Peddio Stefania, Lorrai Sonia, Padiglia Alessandra, Cannea Faustina B, Dettori Tinuccia, Cristiglio Viviana, Genovese Luigi, Zucca Paolo, Rescigno Antonio
Department of Biomedical Sciences (DiSB), University Campus, Monserrato, 09042 Cagliari, Italy.
Department of Life and Environmental Sciences (DiSVA), University Campus, Monserrato, 09042 Cagliari, Italy.
Plants (Basel). 2023 Aug 11;12(16):2918. doi: 10.3390/plants12162918.
α-amylase inhibitor (α-AI) is a protein that has recently gained commercial interest, as it inhibits mammalian α-amylase activity, reducing the absorption of dietary carbohydrates. Numerous studies have reported the efficacy of preparations based on this protein on the control of glycaemic peaks in type-2 diabetes patients and in overweight subjects. A positive influence on microbiota regulation has also been described. In this work, ten insufficiently studied Italian cultivars were screened for α-amylase- and α-glucosidase-inhibiting activity, as well as for the absence of antinutritional compounds, such as phytohemagglutinin (PHA). All the cultivars presented α-glucosidase-inhibitor activity, while α-AI was missing in two of them. Only the Nieddone cultivar (ACC177) had no haemagglutination activity. In addition, the partial nucleotide sequence of the α-AI gene was identified with the degenerate hybrid oligonucleotide primer (CODEHOP) strategy to identify genetic variability, possibly linked to functional α-AI differences, expression of the α-AI gene, and phylogenetic relationships. Molecular studies showed that α-AI was expressed in all the cultivars, and a close similarity between the Pisu Grogu and Fasolu cultivars' α-AI and α-AI-4 isoform emerged from the comparison of the partially reconstructed primary structures. Moreover, mechanistic models revealed the interaction network that connects α-AI with the α-amylase enzyme characterized by two interaction hotspots (Asp38 and Tyr186), providing some insights for the analysis of the α-AI primary structure from the different cultivars, particularly regarding the structure-activity relationship. This study can broaden the knowledge about this class of proteins, fuelling the valorisation of Italian agronomic biodiversity through the development of commercial preparations from legume cultivars.
α-淀粉酶抑制剂(α-AI)是一种最近引起商业关注的蛋白质,因为它能抑制哺乳动物的α-淀粉酶活性,减少膳食碳水化合物的吸收。许多研究报告了基于这种蛋白质的制剂对2型糖尿病患者和超重受试者血糖峰值控制的功效。对微生物群调节也有积极影响。在这项工作中,对10个研究不足的意大利品种进行了筛选,检测其α-淀粉酶和α-葡萄糖苷酶抑制活性,以及是否存在抗营养化合物,如植物血凝素(PHA)。所有品种都具有α-葡萄糖苷酶抑制活性,其中两个品种缺乏α-AI。只有尼迪多品种(ACC177)没有血凝活性。此外,采用简并杂交寡核苷酸引物(CODEHOP)策略鉴定了α-AI基因的部分核苷酸序列,以确定可能与功能性α-AI差异、α-AI基因表达和系统发育关系相关的遗传变异性。分子研究表明,α-AI在所有品种中均有表达,通过比较部分重建的一级结构发现,皮苏·格罗古和法索卢品种的α-AI与α-AI-4同工型非常相似。此外,机理模型揭示了连接α-AI与α-淀粉酶的相互作用网络,其特征是有两个相互作用热点(Asp38和Tyr186),这为分析不同品种的α-AI一级结构提供了一些见解,特别是关于结构-活性关系。这项研究可以拓宽对这类蛋白质的认识,通过开发豆类品种的商业制剂来促进意大利农业生物多样性的增值。